Nolan Campbell

Nolan Campbell is a Medical Director at Johnson & Johnson, focusing on US launches of nipocalimab across neuroimmunology indications. They have extensive experience in medical and clinical development, particularly in neurology, neuroimmunology, and neuromuscular disease, having previously held leadership roles at Biogen. Nolan designed and executed multiple clinical studies, significantly contributing to the field through evidence generation and regulatory submissions. An advocate for using rigorous science to enhance medical practice, they are committed to improving patient outcomes. With a PhD in Biology from UC San Diego, Nolan continues to prioritize impactful work in their career.